Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A new method to estimate rCBF using IMP and SPECT without any blood sampling.

S Nishizawa1, T Shiozaki, M Ueno

  • 1Department of Nuclear Medicine and Diagnostic Imaging, Graduate School of Medicine, Kyoto University, Japan. sadahiko@fmsrsa.fukui-med.ac.jp

Annals of Nuclear Medicine
|February 24, 2001
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Risk factors for fracture by same-level falls among workers across sectors: a cross-sectional study of national open database of the occupational injuries in Japan.

Public health·2023
Same author

Atezolizumab plus bevacizumab versus lenvatinib or sorafenib in non-viral unresectable hepatocellular carcinoma: an international propensity score matching analysis.

ESMO open·2022
Same author

Verification of the Usefulness of an Assessment and Risk Control Sheet that Promotes Management of Cancer Drug Therapy.

Frontiers in pharmacology·2022
Same author

Nonalcoholic steatohepatitis in hepatocarcinoma: new insights about its prognostic role in patients treated with lenvatinib.

ESMO open·2021
Same author

A validation study of combined resection and ablation therapy for multiple hepatocellular carcinoma.

Clinical radiology·2021
Same author

Identification of lenvatinib prognostic index via recursive partitioning analysis in advanced hepatocellular carcinoma.

ESMO open·2021

This study introduces a novel method for measuring regional cerebral blood flow (rCBF) using iodine-123 IMP and SPECT without blood sampling. The technique demonstrates reliable rCBF assessment, simplifying the diagnostic process.

Area of Science:

  • Nuclear Medicine
  • Cerebrovascular Physiology
  • Medical Imaging

Background:

  • Regional cerebral blood flow (rCBF) assessment is crucial for diagnosing various neurological conditions.
  • Traditional methods often require invasive arterial blood sampling (ABS), posing risks and inconveniences.
  • Developing non-invasive techniques for accurate rCBF measurement is a significant clinical need.

Purpose of the Study:

  • To develop and validate a novel SPECT-based method for measuring rCBF without the need for arterial blood sampling.
  • To compare the accuracy and reliability of the new method against established techniques using ABS.

Main Methods:

  • Utilized iodine-123 IMP (isopropylamphetamine) and SPECT imaging.
  • Derived arterial input function parameters (TC(T)/CO) from chest dynamic scans, eliminating the need for direct arterial measurements.

Related Experiment Videos

  • Employed a microsphere model analysis for rCBF calculation and validated against a two-compartment model with ABS.

    • Main Results:

    • The developed method (rCBF-test) showed excellent agreement with the reference method (rCBF-ref) derived from SPECT and ABS (mean difference: 1.0 ± 2.7 ml/100 g/min).
    • Percentage changes in rCBF measured by the new method closely correlated with the reference method in longitudinal studies (r = 0.92).
    • The non-invasive technique proved to be reliable for rCBF assessment.

    Conclusions:

    • A reliable and accurate SPECT-based method for measuring rCBF without blood sampling has been successfully developed and validated.
    • This non-invasive approach simplifies the assessment of regional cerebral blood flow, enhancing patient comfort and safety.
    • The method holds significant potential for routine clinical use in evaluating cerebrovascular diseases.